[1] ANDERSON M E.Update on survival in osteosarcoma[J].Orthop Clin North Am,2016,47(1):283-292.
[2] LYRA-GONZALEZ I,FLORES-FONG L E,GONZALEZ-GARCIA I,et al.MicroRNAs dysregulation in hepatocellular carcinoma:insights in genomic medicine[J].World J Hepatol,2015,7(11):1530-1540.
[3] 冯晓云,葛琴,陆志斌.非小细胞肺癌患者血清miR-133b的表达水平及其临床意义探讨[J].东南大学学报:医学版,2015,34(6):934-937.
[4] 李文超,陈明.生物体液MicroRNA在前列腺癌诊断中的研究进展[J].东南大学学报:医学版,2016,35(3):440-442.
[5] TIAN K,DI R,WANG L.MicroRNA-23a enhances migration and invasion through PTEN in osteosarcoma[J].Cancer Gene Ther,2015,22(7):351-359.
[6] ZHANG H,GUO X,FENG X,et al.MiRNA-543 promotes osteosarcoma cell proliferation and glycolysis by partially suppressing PRMT9 and stabilizing HIF-1alpha protein[J].Oncotarget,2016,8(2):2342-2355.
[7] XU E,ZHAO J,MA J,et al.miR-146b-5p promotes invasion and metastasis contributing to chemoresistance in osteosarcoma by targeting zinc and ring finger 3[J].Oncol Rep,2016,35(1):275-283.
[8] LU T,ZHANG C,CHAI M X,et al.MiR-374a promotes the proliferation of osteosarcoma cell proliferation by targeting Axin2[J].Int J Clin Exp Pathol,2015,8(9):10776-10783.
[9] LI Z,LI Y,WANG N,et al.miR-130b targets NKD2 and regulates the Wnt signaling to promote proliferation and inhibit apoptosis in osteosarcoma cells[J].Biochem Biophys Res Commun,2016,471(4):479-485.
[10] LI Y,ZHANG J,ZHANG L,et al.Diallyl trisulfide inhibits proliferation,invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling[J].Carcinogenesis,2013,34(7):1601-1610.
[11] NOVELLO C,PAZZAGLIA L,CONTI A,et al.p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression[J].PLoS One,2014,9(12):e114757.
[12] GHANDADI M,SAHEBKAR A.MicroRNA-34a and its target genes:key factors in cancer multidrug resistance[J].Curr Pharm Des,2016,22(7):933-939.
[13] BAE Y,YANG T,ZENG H C,et al.miRNA-34c regulates Notch signaling during bone development[J].Hum Mol Genet,2012,21(13):2991-3000.
[14] JIN J,CAI L,LIU Z M,et al.miRNA-218 inhibits osteosarcoma cell migration and invasion by down-regulating of TIAM1,MMP2 and MMP9[J].Asian Pac J Cancer Prev,2013,14(6):3681-3684.
[15] MIN D,LIN F,SHEN Z,et al.Analysis of prognostic factors in 333 Chinese patients with high-grade osteosarcoma treated by multidisciplinary combined therapy[J].Asia Pac J Clin Oncol,2013,9(1):71-79.
[16] ZHOU G,LU M,CHEN J,et al.Identification of miR-199a-5p in serum as noninvasive biomarkers for detecting and monitoring osteosarcoma[J].Tumour Biol,2015,36(11):8845-8852.
[17] WANG N G,WANG D C,TAN B Y,et al.Down-regulation of microRNA152 is associated with the diagnosis and prognosis of patients with osteosarcoma[J].Int J Clin Exp Pathol,2015,8(8):9314-9319.
[18] WANG T,JI F,DAI Z,et al.Increased expression of microRNA-191 as a potential serum biomarker for diagnosis and prognosis in human osteosarcoma[J].Cancer Biomark,2015,15(5):543-550.
[19] YANG Z,ZHANG Y,ZHANG X,et al.Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma[J].Biomed Pharmacother,2015,75:153-158.
[20] TANG J,ZHAO H,CAI H,et al.Diagnostic and prognostic potentials of microRNA-27a in osteosarcoma[J].Biomed Pharmacother,2015,71:222-226.
[21] LIU J D,XIN Q,TAO C S,et al.Serum miR-300 as a diagnostic and prognostic biomarker in osteosarcoma[J].Oncol Lett,2016,12(5):3912-3918.
[22] LIAN D,WANG Z Z,LIU N S.MicroRNA-1908 is a biomarker for poor prognosis in human osteosarcoma[J].Eur Rev Med Pharmacol Sci,2016,20(7):1258-1262.
[23] WANG W,ZHANG L,ZHENG K,et al.miR-17-5p promotes the growth of osteosarcoma in a BRCC2-dependent mechanism[J].Oncol Rep,2016,35(3):1473-1482.
[24] LIAN F,CUI Y,ZHOU C,et al.Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma[J].PLoS One,2015,10(3):e0121499.
[25] LIU W,ZHAO Z Y,SHI L,et al.Tissue microRNA-126 expression level predicts outcome in human osteosarcoma[J].Diagn Pathol,2015,10:116.
[26] LIU S Y,DENG S Y,HE Y B,et al.miR-451 inhibits cell growth,migration and angiogenesis in human osteosarcoma via down-regulating IL 6R[J].Biochem Biophys Res Commun,2016,482(4):987-993.
[27] YANG G,ZHANG P,LU·· A,et al.MiR-205 functions as a tumor suppressor via targeting TGF-alpha in osteosarcoma[J].Exp Mol Pathol,2016,100(1):160-166.
[28] CHEN G,FANG T,HUANG Z,et al.MicroRNA-133a Inhibits Osteosarcoma Cells Proliferation and Invasion via Targeting IGF-1R[J].Cell Physiol Biochem,2016,38(2):598-608.
[29] WU S,DU X,WU M,et al.MicroRNA-409-3p inhibits osteosarcoma cell migration and invasion by targeting catenin-delta1[J].Gene,2016,584(1):83-89.
[30] PU Y,ZHAO F,CAI W,et al.MiR-193a-3p and miR-193a-5p suppress the metastasis of human osteosarcoma cells by down-regulating Rab27B and SRR,respectively[J].Clin Exp Metastasis,2016,33(4):359-372.
[31] LI Z,SHEN J,CHAN M T,et al.MicroRNA-379 suppresses osteosarcoma progression by targeting PDK1[J].J Cell Mol Med,2016,21(2):315-323.
[32] CHEN B,HUANG Z,ZHANG Y,et al.MicroRNA-145 suppresses osteosarcoma metastasis via targeting MMP16[J].Cell Physiol Biochem,2015,37(6):2183-2193.
[33] ZIYAN W,YANG L.MicroRNA-21 regulates the sensitivity to cisplatin in a human osteosarcoma cell line[J].Ir J Med Sci,2016,185(1):85-91.
[34] LI Y,JIANG W,HU Y,et al.MicroRNA-199a-5p inhibits cisplatin-induced drug resistance via inhibition of autophagy in osteosarcoma cells[J].Oncol Lett,2016,12(5):4203-4208.
[35] CHEN S M,CHOU W C,HU L Y,et al.The effect of microRNA-124 overexpression on anti-tumor drug sensitivity[J].PLoS One,2015,10(6):e0128472. |
